Abstract Immune-mediated uveitis is a collective term referring to a group of potentially blinding intraocular inflammations which may coexist with systemic inflammatory diseases. T lymphocytes appear to play an important pathogenic role in uveitis, and these cells are therefore the logical target of drug therapy. Corticosteroids act nonspecifically, but are highly effective in controlling the inflammation rapidly. They are administered locally when disease is confined to the anterior portion of the eye. However, posterior eye involvement often requires systemic corticosteroid therapy, carrying a high risk of serious adverse effects when used for extended periods. In this situation, steroid-sparing agents are used. Few relevant randomised, controlled clinical trials have been performed, and the choice of systemic immunosuppressive regimen is usually guided by individual patient characteristics, cost, drug availability and physician preference. Patients should actively participate in therapeutic decision-making. Our first choice for steroid-sparing medication is often methotrexate, an anti-metabolite which carries a low risk of adverse reactions when appropriately prescribed and monitored, is relatively inexpensive, and has once-weekly ease of use. For more severe uveitis, we may combine the immunomodulating agent cyclosporin with methotrexate and a corticosteroid. Azathioprine and cyclophosphamide are other treatment options. Steroid-sparing drugs also have significant potential for causing adverse effects, albeit less frequently than corticosteroids. Future therapies aim to reduce this problem by increasing the specificity of the therapeutic action.
cells               0.9999999999961346^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

eye                           0.9999999999809006^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

medication                    0.9999999966059931^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

adverse effects               0.999999997738314^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Adverse_effect        

methotrexate                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methotrexate          

Immune-mediated               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immune_disorder       

adverse effects               0.999999997738314^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Adverse_effect        

cyclophosphamide              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclophosphamide      

disease                       0.9999999844683317^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infection             

inflammations                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

uveitis                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Uveitis               

drug                          0.9999991141455042^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

drug therapy                  0.9995284444336944^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

corticosteroids               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

corticosteroid                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

specificity                   0.999988161641838^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Sensitivity_and_specificity

Azathioprine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Azathioprine          

inflammatory diseases         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

eye                           0.9999999999809006^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

T lymphocytes                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/T_cell                

Corticosteroids               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

controlled clinical trials    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

anterior                      0.5937836552396734^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anterior_pituitary    

inflammation                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

posterior                     0.8822597532195908^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

adverse reactions             0.9999999947181095^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

corticosteroid                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Corticosteroid        

pathogenic                    0.9999999868002761^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pathogen              

uveitis                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Uveitis               

methotrexate                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methotrexate          

uveitis                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Uveitis               

immunosuppressive             0.8227032485120301^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Immunosuppression     

drugs                         0.9999989475760311^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

cyclosporin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ciclosporin           

immunomodulating              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunotherapy         

physician                     0.9999946032221595^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Health_care_provider  

